Your session is about to expire
← Back to Search
TTHX1114 Dose Level 1 for Corneal Epithelial Degeneration (EPI Trial)
EPI Trial Summary
This trial will gradually increase the dose to find the best and safest amount to take.
EPI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEPI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 157 Patients • NCT02003391EPI Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals over 75 years old precluded from participating in this experiment?
"The entry requirements for this trial entail that participants must be 18 years old or older, yet not exceed 65."
Are there any vacancies available for participants of this research project?
"This clinical trial, which was initially posted on December 6th 2022 is still recruiting patients. The information hosted on clinicaltrials.gov was last updated in March 3rd of 2023."
Has TTHX1114 Dose Level 1 been certified by the FDA?
"Our team has assigned TTHX1114 Dose Level 1 a score of 1 because the clinical data available is restricted to Phase 1 trials, which lack sufficient evidence for safety and efficacy."
Who qualifies for inclusion in this experiment?
"Patients with corneal epithelial degeneration aged 18-65 are eligible to apply for this clinical trial, which is seeking around 30 participants."
What is the cap on enrollment for this clinical experiment?
"Affirmative, the clinicaltrials.gov page for this therapeutic trial confirms that it is actively recruiting participants. This study was initially announced on December 6th 2022 and updated as recently as March 3rd 2023. The research team requires 30 individuals to be recruited from a single medical centre."
Share this study with friends
Copy Link
Messenger